STAT+: Compass says its psilocybin drug helped patients with severe depression in two trials
COMP360 could be the first psilocybin-based medicine to win approval.
Health
Health Bulletin 17/February/2026
Here are the top health stories for the day:Gynaecologists Body Urges NMC to Reconsider NEET PG 2025 Cutoff ReductionA gynaecologist's body has urged the National Medical Commission (NMC), its Postgraduate…
Fortis Hospital Mohali receives bomb threat email, police launch investigation
Chandigarh: Fortis Hospital in Punjab's Mohali received bomb threat email on Tuesday, prompting police to launch a search operation, officials said.According to a recent PTI report, a senior police official…
NMC to move Supreme Court against Delhi HC order on MBBS migration ban
New Delhi: After the Delhi High Court struck down the blanket ban on migration of MBBS students under the NMC Graduate Medical Education Regulations, 2023, the National Medical Commission (NMC)…
Govt plans AI, e-book access for 57 govt medical colleges students
New Delhi: The Centre is planning to provide AI-enabled learning resources and access to e-books for medical students, beginning with 57 government medical colleges located in smaller towns and rural…
Lilavati Hospital Trustee Rajesh Mehta terminated over financial fraud, coercion allegations
Mumbai: In a major development, the Lilavati Kirtilal Mehta Medical Trust, which manages Lilavati Hospital and Research Centre, on Monday terminated permanent trustee Rajesh Mehta following allegations of financial fraud,…
2980 seats up for grabs in MCC NEET PG 2025 counselling stray vacancy round, check complete details HERE
New Delhi: The Medical Counselling Committee (MCC) has released the clear vacancy for the Stray Round (MD, MS and DNB) NEET PG Counselling for the academic year 2025. The vacancy…
JnK Terror Probe: Radicalisation among doctors, Ansar Interim under scanner
New Delhi: A recently uncovered terror module in Jammu and Kashmir has exposed a worrying trend of alleged radicalisation among professionals, including doctors. Authorities claim that individuals were involved in…
Real-World Study Shows Sustained Glycaemic Benefit and Acceptable Safety of Imeglimin in Type 2 Diabetes
Japan: A recent real-world study finds that imeglimin transforms Type 2 Diabetes (T2D) care by maintaining a 0.8% mean reduction in Glycated Hemoglobin (HbA1c) and an exceptional 86% target achievement…
Coronary Plaque Volume Predicts Heart Events in Newly Diagnosed CAD Patients: PROMISE Substudy
USA: A recent analysis of the PROMISE randomized clinical trial suggests that measuring the volume and burden of coronary plaque may help predict major adverse cardiovascular events (MACE) in patients…